Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

624 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The use of Imatinib resistance mutation analysis to direct therapy in Philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukaemia patients failing Imatinib treatment, in Patan Hospital, Nepal.
Kayastha GK, Ranjitkar N, Gurung R, Kc RK, Karki S, Shrestha R, Rajbhandari P, Thapa RK, Poudyal B, Acharya P, Roberts DJ, Hayes B, Zimmerman M, Basnyat B. Kayastha GK, et al. Among authors: acharya p. Br J Haematol. 2017 Jun;177(6):1000-1007. doi: 10.1111/bjh.14683. Epub 2017 May 3. Br J Haematol. 2017. PMID: 28467002 Free article. Review.
Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor.
Kayastha GK, Gurung P, Acharya PK, Paudyal BP, Hayes B, Zimmerman M, Karki A, Mansfield AS. Kayastha GK, et al. Among authors: acharya pk. BMC Blood Disord. 2010 Dec 7;10:8. doi: 10.1186/1471-2326-10-8. BMC Blood Disord. 2010. PMID: 21138592 Free PMC article.
Treating Philadelphia chromosome/BCR-ABL1 positive patients with Glivec (Imatinib mesylate): 10 years' experience at Patan Hospital, Nepal.
Kayastha GK, Ranjitkar N, Gurung R, Kc RK, Karki S, Shrestha R, Thapa RK, Rajbhandari P, Poudyal B, Acharya P, Roberts DJ, Hayes B, Zimmerman M, Basnyat B, Mansfield A. Kayastha GK, et al. Among authors: acharya p. Br J Haematol. 2017 Jun;177(6):991-999. doi: 10.1111/bjh.14645. Epub 2017 Mar 29. Br J Haematol. 2017. PMID: 28369812 Free article.
Public Health Approach to Developing Palliative Care.
Baral KP, Bista K, Lama C, Acharya PK, Vaidya P, Gongal RN. Baral KP, et al. Among authors: acharya pk. JNMA J Nepal Med Assoc. 2022 Aug 1;60(252):750-752. doi: 10.31729/jnma.7255. JNMA J Nepal Med Assoc. 2022. PMID: 36705226 Free PMC article.
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.
Williams WB, Alam SM, Ofek G, Erdmann N, Montefiori DC, Seaman MS, Wagh K, Korber B, Edwards RJ, Mansouri K, Eaton A, Cain DW, Martin M, Hwang J, Arus-Altuz A, Lu X, Cai F, Jamieson N, Parks R, Barr M, Foulger A, Anasti K, Patel P, Sammour S, Parsons RJ, Huang X, Lindenberger J, Fetics S, Janowska K, Niyongabo A, Janus BM, Astavans A, Fox CB, Mohanty I, Evangelous T, Chen Y, Berry M, Kirshner H, Van Itallie E, Saunders KO, Wiehe K, Cohen KW, McElrath MJ, Corey L, Acharya P, Walsh SR, Baden LR, Haynes BF. Williams WB, et al. Among authors: acharya p. Cell. 2024 Jun 6;187(12):2919-2934.e20. doi: 10.1016/j.cell.2024.04.033. Epub 2024 May 17. Cell. 2024. PMID: 38761800 Free article.
A Pillar/Perfusion Plate Enhances Cell Growth, Reproducibility, Throughput, and User Friendliness in Dynamic 3D Cell Culture.
Lekkala VKR, Kang SY, Liu J, Shrestha S, Acharya P, Joshi P, Zolfaghar M, Lee M, Vanga MG, Jamdagneya P, Pagnis S, Kundi A, Kabbur S, Kim UT, Yang Y, Lee MY. Lekkala VKR, et al. Among authors: acharya p. ACS Biomater Sci Eng. 2024 May 13;10(5):3478-3488. doi: 10.1021/acsbiomaterials.4c00179. Epub 2024 May 2. ACS Biomater Sci Eng. 2024. PMID: 38695610
624 results